SMARTGNOSTICS
Mobilizing Agendes/Alliances for Reindustrialization - Application No. 5
The SmartGnostics project aims to develop innovative POC devices for the global monitoring of antibiotic-resistant pathogens, as well as of the antibiotics themselves and waste. The devices to be developed in this project would represent an important step in the fight against AMR, providing a basis for international action, implementing mitigation strategies, and evaluating the progress achieved. Thus, this project covers the 4 pillars of the AMR cycle: Human Health, Animal Health, Environment, and Food Safety.
ALS LIFE SCIENCES PORTUGAL, S.A.
NATIONAL INSTITUTE FOR AGRARIAN AND VETERINARY RESEARCH, I.P.
INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY (LIN)
UNIVERSITY OF MINHO
INESC TEC - INSTITUTE OF SYSTEMS AND COMPUTER ENGINEERING, TECHNOLOGY AND SCIENCE
INEGI - INSTITUTE OF SCIENCE AND INNOVATION IN MECHANICAL ENGINEERING AND INDUSTRIAL ENGINEERING
NATIONAL INSTITUTE OF HEALTH DR. RICARDO JORGE, I.P.
INSTITUTE OF PUBLIC HEALTH OF THE UNIVERSITY OF PORTO
SPMAQ-SOLUTIONS PROJECTS MAQUINAS UNIPERSONAL LDA
FRESENIUS KABI PHARMA PORTUGAL LDA
UNIVERSITY-BUSINESS ASSOCIATION FOR DEVELOPMENT - TECMINHO
20/07/2022
01/01/2023
31/12/2025
20,924,584.02 euros
15,647,204.01 euros
Antibiotic resistance (AMR) represents a significant global threat of vast proportions. Drug-resistant infections are estimated to cause around 5 million deaths every year. In the European Union, more than 33,000 people die annually due to AMR, with an economic impact of approximately €1.5 billion/year in health costs and lost productivity. The WHO declared AMR as one of the 10 major threats to global public health and requested that all countries implement national action plans to prevent the indiscriminate use of antibiotics. Therefore, it is a serious public health crisis affecting global economies. The WHO estimates that, if no action is taken, the number of deaths is expected to rise to 10 million a year by 2050, surpassing diabetes, heart disease, and cancer as the leading cause of death.
Antibiotic resistance (AMR) is a complex process that occurs when bacteria adapt to the continuous presence of antibiotics, resulting in new bacterial strains that no longer respond to antibiotic treatments. This makes infections virtually untreatable, increasing the risk of spreading illness, serious illness, and death.
The SmartGnostics project proposes a holistic “One Health” approach to the problem of AMR, through the development of devices/solutions to combat bacteria, AMR genes and antibiotic residues in various fields that make up the AMR cycle: human and animal health, food safety and the environment. The objective is to develop point-of-care (POC) solutions that can be simultaneously “lab-on-a-chip”, coupled with data acquisition and processing through Artificial Intelligence (AI), providing integrated data for predictive analyses of future AMR and/or pathogen genes. This will provide an Early Warning System to control/monitor/prevent a future “superbug” pandemic.
Photovoltaic system for self-consumption 90470Wp
Support for Industry Decarbonization (Modality A)
The photovoltaic system for self-consumption 90470Wp project aims to implement the photovoltaic system for self-consumption in order to significantly reduce the energy consumption of the public grid, in productive activities and to make the company more sustainable and energy efficient. It promotes the reduction of greenhouse gas emissions.
SPMAQ-SOLUTIONS PROJECTS MÁQUINAS UNIPERSONAL LDA
15/03/2023
23/01/2023
31/12/2023
72,007.25 euros
61,206.16 euros
.png)
.svg)
.svg)
.svg)
.png)
.svg)
